Recently, the Port Klang Central Hospital (HTAR) in Malaysia successfully completed a high-difficulty laparoscopic cholecystectomy using Affacare Ultrasonic Surgical System, which is an important step forward in the application of the Affacare Ultrasonic Surgical system in that region.

The focus of the surgery was on the patient's rare Mirizzi syndrome, a complex condition that accounts for only 1% of cholelithiasis-related cases. The surgical difficulty of this disease is extremely high. However, the surgical team at HTAR Hospital successfully overcame this challenge with their superb skills and the outstanding performance of Affacare Ultrasonic Surgical System. The surgery lasted for six hours and went smoothly, with the patient recovering well postoperatively. The surgeons highly praised the performance of Affacare Ultrasonic Surgical System, stating that it is comparable to similar products from international companies in terms of cutting precision and hemostasis effect, and even has certain advantages in some aspects.

As a key government hospital in Port Klang, HTAR Hospital has always been a benchmark for medical technology in that region. The success of this surgery not only demonstrated the hospital's high level of expertise in the field of surgery but also provided strong case support for the promotion of Affacare Ultrasonic Surgical System in Malaysia. The Clinical Research Center (CRC) of HTAR Hospital has been at the forefront of research and application of minimally invasive surgical techniques. By continuously introducing advanced medical equipment and technologies, the hospital has provided patients with safer and more efficient treatment options and has set a new standard for regional medical technology development.

The successful application at Port Klang Central Hospital marks a significant breakthrough for Affacare Ultrasonic Surgical System in the Southeast Asian market. Affacare Ultrasonic Surgical System will continue focusing on providing best energy surgical products to serve medical institutions globally, will further explore the potential of minimally invasive surgery and provide more treatment options for patients worldwide.